FMO5 and chronic granulomatous disease: Individuals with inherited, disabling mutations of genes that contribute to the NADPH oxidase system, develop a primary immunodeficiency termed chronic granulomatous disease (CGD) that is characterised by recurrent bacterial and fungal infections [29].